Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

The Dfl mutation in mice causes poor sebaceous gland function and complete hair loss.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Hair and skin healing involve complex cell interactions controlled by specific molecules and pathways, and hair follicle cells can help repair skin wounds.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Plucked hair follicles can help diagnose scalp lupus.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

A new treatment using gold nanoclusters can safely reduce unwanted hair growth.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

IBD treatment is complex and requires personalized approaches due to varying patient responses.

GPCRs are vital for wound healing by affecting cell growth and immune response.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

A woman's scalp infection caused by a fungus led to permanent hair loss and was hard to treat but responded to a specific antifungal.

Topical metformin shows promise for treating skin conditions like acne and psoriasis.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Minoxidil works faster, but ketoconazole is a safer alternative for female hair loss.

0.05% betamethasone dipropionate is the most effective treatment for mild alopecia areata.

Vitamin D may help reduce inflammation in acne.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Bimatoprost solution 0.03% is effective for treating sparse eyelashes.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.